Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Orion Group Holdings
ORN
$392M
| $1.45M | ﹤0.01% |
266,719
| – | – |
|
3502
Wrap Technologies
WRAP
$97.4M
| $1.45M | ﹤0.01% |
241,286
+18,641
| +8% | +$130K |
|
3503
Gyre Therapeutics
GYRE
$693M
| $1.44M | ﹤0.01% |
46,872
+2,541
| +6% | +$83.6K |
|
|
OSG
3504
DELISTED
Overseas Shipholding Group Inc.
OSG
| $1.44M | ﹤0.01% |
694,435
+89,484
| +15% | +$224K |
|
3505
Cabaletta Bio
CABA
$442M
| $1.44M | ﹤0.01% |
118,640
+978
| +0.8% | +$9.02K |
|
|
TIO
3506
DELISTED
Tingo Group, Inc. Common Stock
TIO
| $1.44M | ﹤0.01% |
927,811
+38,888
| +4% | +$72.3K |
|
|
IMPL
3507
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $1.44M | ﹤0.01% |
117,916
+66,974
| +131% | +$972K |
|
3508
Nano X Imaging
NNOX
$73.2M
| $1.43M | ﹤0.01% |
63,617
+3,161
| +5% | +$83K |
|
|
PBPB
3509
DELISTED
Potbelly
PBPB
| $1.43M | ﹤0.01% |
211,105
+2,499
| +1% | +$17.4K |
|
3510
Hawthorn Bancshares
HWBK
$277M
| $1.42M | ﹤0.01% |
66,142
-580
| -0.9% | -$12.2K |
|
3511
Unity Bancorp
UNTY
$620M
| $1.42M | ﹤0.01% |
60,479
+3,956
| +7% | +$90.5K |
|
3512
Energy Transfer Partners
ET
$71.5B
| $1.41M | ﹤0.01% |
147,665
+11,276
| +8% | +$108K |
|
3513
Corbus Pharmaceuticals
CRBP
$195M
| $1.41M | ﹤0.01% |
46,204
+956
| +2% | +$37.7K |
|
3514
ReNew
RNW
$2.48B
| $1.41M | ﹤0.01% |
+138,236
| New | +$1.38M |
|
|
AAIC
3515
DELISTED
Arlington Asset Investment Corp.
AAIC
| $1.4M | ﹤0.01% |
378,843
+55,393
| +17% | +$211K |
|
|
LNAI
3516
Lunai Bioworks
LNAI
$10.2M
| $1.4M | ﹤0.01% |
2,595
+744
| +40% | +$363K |
|
3517
Energous
WATT
$82M
| $1.4M | ﹤0.01% |
1,118
+290
| +35% | +$415K |
|
|
EARN
3518
Ellington Residential Mortgage REIT
EARN
$167M
| $1.39M | ﹤0.01% |
124,747
+48,895
| +64% | +$553K |
|
|
DLA
3519
DELISTED
Delta Apparel Inc.
DLA
| $1.39M | ﹤0.01% |
50,951
| – | – |
|
|
TTOO
3520
DELISTED
T2 Biosystems, Inc
TTOO
| $1.39M | ﹤0.01% |
303
+4
| +1% | +$20.1K |
|
3521
Ramaco Resources Class A
METC
$667M
| $1.39M | ﹤0.01% |
116,396
+42,081
| +57% | +$350K |
|
3522
Choiceone Financial
COFS
$515M
| $1.38M | ﹤0.01% |
56,282
+10,986
| +24% | +$270K |
|
|
NVVE
3523
DELISTED
Nuvve Holding Corp
NVVE
| – | – |
0
| – | – |
|
|
CLYM
3524
Climb Bio
CLYM
$846M
| $1.38M | ﹤0.01% |
+76,904
| New | +$1.59M |
|
|
BRFS
3525
DELISTED
BRF SA
BRFS
| $1.38M | ﹤0.01% |
274,507
-20
| -0% | -$94 |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.